Llwytho...

Tapentadol extended-release for treatment of chronic pain: a review

Tapentadol is a centrally acting analgesic with a dual mechanism of action of mu receptor agonism and norepinephrine reuptake inhibition. Tapentadol immediate-release is approved by the US Food and Drug Administration for the management of moderate-to-severe acute pain. It was developed to decrease...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Vadivelu, Nalini, Timchenko, Alexander, Huang, Yili, Sinatra, Raymond
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Dove Medical Press 2011
Pynciau:
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC3160834/
https://ncbi.nlm.nih.gov/pubmed/21887118
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/JPR.S14842
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!